Qian Lei

Dr. Qian Lei

orcid

Research Focus & Metrics

Academic Career Length

18Years (2009-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
7 August 2020 in Basic Research in Cardiology
Verified
Journal Article
Closed access
PDF file
JLJuanjuan Lyu
Juanjuan Lyu
MWMan Wang
Man Wang
XKXinjiang Kang
Xinjiang Kang
HXHuadong Xu
Huadong Xu
ZCZhongming Cao
Zhongming Cao
QLQian Lei
Qian Lei

15 June 2024 in Cell Death Discovery
Verified
Journal Article
Open access
PDF file
JLJun Liu
Jun Liu
FLFeila Liu
Feila Liu
TLTingting Liang
Tingting Liang
YZYue Zhou
Yue Zhou
XSXiaohan Su
Xiaohan Su
PCPanke Cheng
Panke Cheng
Myocardial infarction, commonly known as a heart attack, is a serious condition caused by the abrupt stoppage of blood flow to a part of the heart, leading to tissue damage. A significant aspect of this condition is reperfusion injury, which occurs when blood flow is restored but exacerbates the damage. This review first addresses the role of the innate immune system, including neutrophils and macrophages, in the cascade of events leading to myocardial infarction and reperfusion injury. It then shifts focus to the critical involvement of CD4+ T helper cells in these processes. These cells, pivotal in regulating the immune response and tissue recovery, include various subpopulations such as Th1, Th2, Th9, Th17, and Th22, each playing a unique role in the pathophysiology of myocardial infarction and reperfusion injury. These subpopulations contribute to the injury process through diverse mechanisms, with cytokines such as IFN-γ and IL-4 influencing the balance between tissue repair and injury exacerbation. Understanding the interplay between the innate immune system and CD4+ T helper cells, along with their cytokines, is crucial for developing targeted therapies to mitigate myocardial infarction and reperfusion injury, ultimately improving outcomes for cardiac patients.

6 September 2023 in Pharmaceutics
Verified
Journal Article
Open access
PDF file
SGShiyao Gu
Shiyao Gu
QLQingyong Luo
Qingyong Luo
CWCen Wen
Cen Wen
YZYu Zhang
Yu Zhang
LLLi Liu
Li Liu
SZSi Zeng
Si Zeng
There has been increasing interest and rapid developments in precision medicine, which is a new medical concept and model based on individualized medicine with the joint application of genomics, bioinformatics engineering, and big data science. By applying numerous emerging medical frontier technologies, precision medicine could allow individualized and precise treatment for specific diseases and patients. This article reviews the application and progress of advanced technologies in the anesthesiology field, in which nanotechnology and genomics can provide more personalized anesthesia protocols, while 3D printing can yield more patient-friendly anesthesia supplies and technical training materials to improve the accuracy and efficiency of decision-making in anesthesiology. The objective of this manuscript is to analyze the recent scientific evidence on the application of nanotechnology in anesthesiology. It specifically focuses on nanomedicine, precision medicine, and clinical anesthesia. In addition, it also includes genomics and 3D printing. By studying the current research and advancements in these advanced technologies, this review aims to provide a deeper understanding of the potential impact of these advanced technologies on improving anesthesia techniques, personalized pain management, and advancing precision medicine in the field of anesthesia.

25 November 2023 in British Journal of Anaesthesia
Verified
Journal Article
Closed access
YZYujun Zhang
Yujun Zhang
YJYingying Jiang
Yingying Jiang
QLQian Lei
Qian Lei
CLChaoyu Li
Chaoyu Li
SJShu'AN Jin
Shu'AN Jin
WZWensheng Zhang
Wensheng Zhang

1 September 2021 in Current Alzheimer Research
Verified
Journal Article
Closed access
PDF file
JZJian-Jun Zhang
Jian-Jun Zhang
ZZZe- Xuan- Zhu
Ze- Xuan- Zhu
GXGuang- Min- Xu
Guang- Min- Xu
PSPeng Su
Peng Su
QLQian Lei
Qian Lei
WLWei Li
Wei Li
Background: Alzheimer's disease (AD) is still one of the major threats to human health. Although a satisfactory treatment for AD has not yet been discovered, it is necessary to continue to search for novel approaches to deal with this insidious and debilitating disease. Although numerous studies have shown that long non-coding RNA (lncRNA) occupy a significant role in a variety of diseases, their roles in AD remain unclear. Objectives: Using data analysis to explore the role of lncRNA in the course of AD, to further our understanding of AD, and to look forward to finding a new breakthrough for the treatment of AD. Methods: We downloaded and screened expression data of the hippocampal regions of patients with AD from the Gene Expression Omnibus database. We generated lncRNA-miRNA-mRNA networks based on the competing endogenous RNA (ceRNA) hypothesis, and according to gene expression level, we constructed a coding-noncoding co-expression (CNC) network and then executed cis- and trans-regulation analyses. Results: Through comprehensive and systematic analyses, we found that lncRNAs MALAT1, OIP5-AS1, LINC00657, and lnc-NUMB-1 regulated the expression of the key AD pathogenic genes APP, PSEN1, BACE1; and that these lncRNAs may promote the distribution of β-amyloid (Aβ protein) in the brain through exosomes. In addition, lncRNAs were found to adjust viral transcriptional expression, thereby further supporting viral pathogenesis for AD. Conclusions: The lncRNAs MALAT1, OIP5-AS1, LINC00657, and lnc-NUMB-1 that are present in the hippocampus of AD patients exert an important influence on the development of this disease.

1 December 2009 in Journal of Cardiothoracic and Vascular Anesthesia
Verified
Journal Article
Closed access
QLQian Lei
Qian Lei
LCLei Chen
Lei Chen
MJMu Jin
Mu Jin
HJHongwen Ji
Hongwen Ji
QYQinjun Yu
Qinjun Yu
LLLihuan Li
Lihuan Li